However, to add to the complexity of CD47 regulation by SEs, we found that not all the breast cancer subtypes have associated SEs with CD47. Breast cancer is divided into five subtypes with distinguishable features and distinct clinical outcomes, based on the expression of ER, PR, HER2, CK5/6 and EGFR markers38. Here, ERBB2 is linked to breast carcinoma.